The Evaluation of Anti-interference Ability and Clinical Specificity of HIV Ag +Ab Assay Kit (Sysmex)

Qianfoshan Hospital

Status: Not yet enrolling

Conditions: Blood Disease; Cancer; HIV Seropositivity

Treatments: Diagnostic Test: HIV Ag +Ab Assay Kit (Sysmex)

Study type: Observational

Funder types: Other

Identifiers

NCT05983536

89269678

Details and patient eligibility

About

To evaluate the anti-interference and specificity of HIV Ag +Ab Assay Kit (Sysmex) for the detection of HIV antigens and antibodies.

Full description

First,HIV Ag +Ab Assay Kit (Sysmex)Assay Kit (Sysmex) was used to detect HIV antigens and antibodies in the serum of patients with tumor and blood diseases, and then confirmed by using the gold standard for HIV diagnosis,human immunodeficiency virus (HIV type 1+2) antibody assay kit (immunoimprinting). The specificity of HIV Ag +Ab Assay Kit (Sysmex) for HIV assay in patients with tumor and hematological diseases was calculated.

Enrollment: 1,200 estimated patients

Sex: All

Ages: 18 to 100 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Clinical diagnosis of tumor Disease or blood disease
• Blood samples must meet the test requirements

Exclusion criteria

• N/A

Trial design

1,200 participants in 2 patient groups

Cancer patients

Description:

Cancer patints that confirmed by pathological examination

Treatment:

Diagnostic Test: HIV Ag +Ab Assay Kit (Sysmex)

Patients with blood diseases

Description:

Bone marrow aspiration and biopsy confirmed the blood disease

Treatment:

Diagnostic Test: HIV Ag +Ab Assay Kit (Sysmex)